GATTI, GIULIANA
 Distribuzione geografica
Continente #
NA - Nord America 2.268
AS - Asia 1.565
EU - Europa 1.286
SA - Sud America 157
AF - Africa 83
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.363
Nazione #
US - Stati Uniti d'America 2.223
CN - Cina 777
IE - Irlanda 333
SG - Singapore 331
HK - Hong Kong 173
UA - Ucraina 154
DE - Germania 138
FI - Finlandia 138
RU - Federazione Russa 130
BR - Brasile 117
VN - Vietnam 100
IT - Italia 88
SE - Svezia 83
GB - Regno Unito 79
FR - Francia 62
ZA - Sudafrica 56
BD - Bangladesh 42
IN - India 42
CA - Canada 29
BE - Belgio 20
JP - Giappone 18
AR - Argentina 16
PL - Polonia 14
IQ - Iraq 12
MX - Messico 11
TR - Turchia 11
ES - Italia 10
ID - Indonesia 9
PK - Pakistan 9
NL - Olanda 8
LT - Lituania 6
MA - Marocco 6
MY - Malesia 6
VE - Venezuela 6
CO - Colombia 5
CZ - Repubblica Ceca 5
SA - Arabia Saudita 5
TN - Tunisia 5
AT - Austria 4
BG - Bulgaria 4
EC - Ecuador 4
KR - Corea 4
PY - Paraguay 4
AM - Armenia 3
AU - Australia 3
BY - Bielorussia 3
DZ - Algeria 3
JO - Giordania 3
PH - Filippine 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BJ - Benin 2
CL - Cile 2
CR - Costa Rica 2
EE - Estonia 2
EG - Egitto 2
KE - Kenya 2
MU - Mauritius 2
OM - Oman 2
TH - Thailandia 2
TJ - Tagikistan 2
AZ - Azerbaigian 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NE - Niger 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.363
Città #
Dublin 333
Chandler 278
Dallas 250
San Jose 213
Jacksonville 201
Singapore 191
Ashburn 183
Hong Kong 171
Beijing 161
Nanjing 159
Ann Arbor 82
Boardman 78
Los Angeles 74
Johannesburg 55
Princeton 52
Changsha 51
Lawrence 50
Nanchang 50
Lauterbourg 45
Wilmington 45
Shenyang 40
Ho Chi Minh City 39
Helsinki 34
Hebei 33
Jiaxing 31
Munich 31
Tianjin 31
New York 30
Medford 29
Shanghai 29
Buffalo 25
Redondo Beach 24
Hanoi 23
Woodbridge 23
Hangzhou 20
Moscow 20
Brussels 19
Milan 18
São Paulo 17
Tokyo 17
Brooklyn 16
London 15
Houston 14
Orem 14
Chicago 12
The Dalles 12
Turku 12
Chennai 11
Council Bluffs 11
Frankfurt am Main 11
San Francisco 11
Warsaw 11
Denver 9
Montreal 9
Pavia 9
Pune 9
Atlanta 8
Des Moines 8
Santa Clara 8
Columbus 7
Toronto 7
Verona 7
Zhengzhou 7
Da Nang 6
Guangzhou 6
Manchester 6
Stockholm 6
Baghdad 5
Fairfield 5
Istanbul 5
Jakarta 5
Mexico City 5
New Delhi 5
Norwalk 5
Palermo 5
Rome 5
Seattle 5
Taizhou 5
Amsterdam 4
Dhaka 4
Nuremberg 4
Piscataway 4
Poplar 4
Sofia 4
Asunción 3
Berlin 3
Boston 3
Brno 3
Charlotte 3
City of London 3
Cologno Monzese 3
Guarulhos 3
Kansas City 3
Las Vegas 3
Minsk 3
Newark 3
Nice 3
Ottawa 3
Phoenix 3
Radomsko 3
Totale 3.644
Nome #
Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and puerperium. 181
A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers. 180
A simple and rapid HPLC-UV method for the determination of retigabine in human plasma 169
Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbamazepine in healthy women 164
A novel enantioselective microassay for the high-performance liquid chromatography determination of oxcarbazepine and its active metabolite monohydroxycarbazepine in human plasma 163
A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. 162
Development and validation of an HPLC-UV detection assay for the determination of rufinamide in human plasma and saliva. 155
A Double-Blind, Placebo-Controlled Study on the Effect of Vigabatrin on In Vivo Parameters of Hepatic Microsomal Enzyme Induction and on the Kinetics of Steroid Oral Contraceptives in Healthy Female Volunteers 147
Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium. 131
Stereoselective determination of vigabatrin enantiomers in human plasma by high performance liquid chromatography using UV detection. 127
A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy 123
Improved enantioselective assay for the determination of fluoxetine and norfluoxetine enantiomers in human plasma by liquid chromatography 121
Clinical pharmacokinetics of fluvoxamine. 120
Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients. 117
Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine sources of variability and preliminary observations on relations with clinical response. 116
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.SOPHIE Study Group. 115
Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial 115
Omeprazole Does Not Enhance the Metabolism of Phenacetin, a Marker of CYP1A2 Activity, in Healthy Volunteers 114
Effect of active and passive cigarette smoking on CYP1A2-mediated phenacetin disposition in Chinese subjects. 114
Enantioselective effects of levodropropizine and dropropizine on psychomotor functions in normal volunteers: a placebo-controlled, double-blind comparative study. 107
A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy 107
Comparative pharmacokinetics and pharmacodynamics of eterobarbital and phenobarbital in normal volunteers. 107
The new antiepileptic drugs: Pharmacological and clinical aspects. 106
Inhibition of diazepam metabolism by fluvoxamine: a pharmacokinetic study in normal volunteers. 105
DIFFERENTIAL-EFFECTS OF VALPROIC ACID AND ENZYME-INDUCING ANTICONVULSANTS ON NIMODIPINE PHARMACOKINETICS IN EPILEPTIC PATIENTS 104
Therapeutic strategies against epilepsy in Mediterranean countries: a report from an international collaborative survey. 101
CYP2D6-related oxidation polymorphism in Italy 100
Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine. 100
The Influence of Dosage, Age, and Comedication on Steady State Plasma Lamotrigine Concentrations in Epileptic Children 99
Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: A clinically relevant pharmacokinetic drug interaction 98
Farmacocinetica delle benzodiazepine. 97
Plasma gabapentin concentrations in children with epilepsy: Influence of age, relationship with dosage, and preliminary observations on correlation with clinical response 95
Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy 94
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy 94
Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients. 92
Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the presence and absence of enzyme induction by carbamazepine. 91
Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects. 91
The Influence of Ethnic Factors and Gender on CYP1A2-Mediated Drug Disposition: A Comparative Study in Caucasian and Chinese Subjects Using Phenacetin as a Marker Substrate 90
The disposition of theophylline in patients with lung and breast cancer. 88
Challenges in the pharmacotherapy of the epilepsies 87
Vigabatrin-induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailability. 85
Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex (silipide) in healthy volunteers. 78
Reduced Plasma Nisoldipine Concentrations in Phenytoin-Treated Patients with Epilepsy 78
Protective effect of cyanidin (IdB 1027) against aspirin-induced fall in gastric transmucosal potential difference in normal subjects. 77
The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid. 76
Influence of dosage, age, and co-medication on plasma topiramate concentrations in children and adults with severe epilepsy and preliminary observations on correlations with clinical response. 75
Off-Label Prescribing of Antiepileptic Drugs in Pharmacoresistant Epilepsy: A Cross-Sectional Drug Utilization Study of Tertiary Care Centers in Italy 74
Pharmacokinetic and pharmacodynamic studies following single and multiple doses of rolafagrel, a novel inhibitor of thromboxane synthase, in normal volunteers 66
The disposition of primidone in elderly patients. 66
Possible enhancement of the first-pass metabolism of prenacetin by grape juice in Chinese subjects 52
Totale 5.414
Categoria #
all - tutte 21.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.081


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 0 0 19
2021/2022210 10 2 4 7 2 6 5 12 13 8 37 104
2022/2023849 91 74 7 53 76 81 0 57 374 4 19 13
2023/2024247 46 40 5 19 25 50 4 23 3 7 12 13
2024/2025763 34 60 17 26 7 58 26 37 185 29 110 174
2025/20262.015 142 216 243 163 215 95 350 120 156 103 149 63
Totale 5.414